Transient oscillatory dynamics of interferon beta signaling in macrophages

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

(2012) Monica Marta et al.   CNS & Neurological Disorders-Drug Targets

Direct Effects of Type I Interferons on Cells of the Immune System

(2011) S. Hervas-Stubbs et al.   CLINICAL CANCER RESEARCH

Suppressor of Cytokine Signaling (SOCS) 1 Inhibits Type I Interferon (IFN) Signaling via the Interferon α Receptor (IFNAR1)-associated Tyrosine Kinase Tyk2

(2011) Rebecca A. R. Piganis et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Systems biology of JAK-STAT signalling in human malignancies

(2011) Julio Vera et al.   PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY

Immune Response Modeling of Interferon β-Pretreated Influenza Virus-Infected Human Dendritic Cells

(2010) Liang Qiao et al.   BIOPHYSICAL JOURNAL

Major Differences in the Responses of Primary Human Leukocyte Subsets to IFN- 

(2010) A. H. H. van Boxel-Dezaire et al.   JOURNAL OF IMMUNOLOGY

Mathematical modelling of interferon-γ signalling in pancreatic stellate cells reflects and predicts the dynamics of STAT1 pathway activity

(2009) Katja Rateitschak et al.   CELLULAR SIGNALLING

Predicting responders to therapies for multiple sclerosis

(2009) Jordi Río et al.   Nature Reviews Neurology

Model-based analysis of interferon-β induced signaling pathway

(2008) Jaroslaw Smieja et al.   BIOINFORMATICS

A logic-based diagram of signalling pathways central to macrophage activation

(2008) Sobia Raza et al.   BMC Systems Biology

Database for mRNA Half-Life of 19 977 Genes Obtained by DNA Microarray Analysis of Pluripotent and Differentiating Mouse Embryonic Stem Cells

(2008) L. V. Sharova et al.   DNA RESEARCH

Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations

(2008) N. Wenta et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA